Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells

This publication has 42 references indexed in Scilit:

• Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin
  International Journal of Cancer, 2003
• TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion
  Journal of Cell Science, 2001
• Transcriptional Cross-talk between Smad, ERK1/2, and p38 Mitogen-activated Protein Kinase Pathways Regulates Transforming Growth Factor-β-induced Aggrecan Gene Expression in Chondrogenic ATDC5 Cells
  Journal of Biological Chemistry, 2001
• Characterization of Binding Properties of Urinary Trypsin Inhibitor to Cell-associated Binding Sites on Human Chondrosarcoma Cell Line HCS-2/8
  Journal of Biological Chemistry, 2001
• Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-β
  Gynecologic Oncology, 2001
• Suppression of Urokinase Expression and Invasiveness by Urinary Trypsin Inhibitor Is Mediated through Inhibition of Protein Kinase C- and MEK/ERK/c-Jun-dependent Signaling Pathways
  Published by Elsevier ,2001
• The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer.
  Surgery Today, 2000
• PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-β1
  Kidney International, 1998
• Metastatic Dissemination of Human Ovarian Epithelial Carcinoma Is Promoted by α2β1-Integrin-Mediated Interaction with Type I Collagen
  Invasion and Metastasis, 1998
• Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent
  British Journal of Cancer, 1995